Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Capitanio

Showing results (51-60 of 516) with videos related to

Pageof 52
Sort By:
The Lancet. Oncology|July 3, 2025
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitorsAlessandro Larcher, Umberto Capitanio, Andrea Necchi, et al.
European Urology|August 16, 2008
The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspectiveUmberto Capitanio, Alberto Briganti, Shahrokh F Shariat, et al.
The Journal of Urology|September 10, 2024
Letter: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell CarcinomaMattia Longoni, Giuseppe Rosiello, Alessandro Larcher, et al.
European Urology Oncology|June 4, 2019
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment DeliveryUmberto Capitanio, Andrea Necchi, Alessandro Larcher, et al.
BJU International|September 11, 2023
To clamp or not to clamp? A step back to go forwardDaniele Cignoli, Andrea Salonia, Roberto Bertini, et al.
Current Opinion in Urology|March 20, 2021
How to improve outcome in nephron-sparing surgery: the impact of new techniquesDaniele Cignoli, Giuseppe Fallara, Alessandro Larcher, et al.
European Urology Oncology|September 17, 2021
Treatment Options for De Novo Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future InsightsDaniel Benamran, Laurence Albiges, Axel Bex, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2024
Biological characterization of renal masses using immuno-PETFabrizia Gelardi, Alessandro Larcher, Lidija Antunovic, et al.
World Journal of Urology|June 9, 2014
Random biopsy: when, how many and where to take the cores?Vincenzo Scattoni, Carmen Maccagnano, Umberto Capitanio, et al.
European Urology|November 17, 2023
Reply to Jared P. Schober, Robert Wang, and Alexander Kutikov's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol. 2023;85:63-71Giuseppe Basile, Giuseppe Fallara, Arturo Chiti, et al.
Pageof 52

Showing results (51-60 of 516) with videos related to

Sort By:
Pageof 52
The Lancet. Oncology|July 3, 2025
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitorsAlessandro Larcher, Umberto Capitanio, Andrea Necchi, et al.
European Urology|August 16, 2008
The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspectiveUmberto Capitanio, Alberto Briganti, Shahrokh F Shariat, et al.
The Journal of Urology|September 10, 2024
Letter: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell CarcinomaMattia Longoni, Giuseppe Rosiello, Alessandro Larcher, et al.
European Urology Oncology|June 4, 2019
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment DeliveryUmberto Capitanio, Andrea Necchi, Alessandro Larcher, et al.
BJU International|September 11, 2023
To clamp or not to clamp? A step back to go forwardDaniele Cignoli, Andrea Salonia, Roberto Bertini, et al.
Current Opinion in Urology|March 20, 2021
How to improve outcome in nephron-sparing surgery: the impact of new techniquesDaniele Cignoli, Giuseppe Fallara, Alessandro Larcher, et al.
European Urology Oncology|September 17, 2021
Treatment Options for De Novo Metastatic Clear-cell Renal Cell Carcinoma: Current Recommendations and Future InsightsDaniel Benamran, Laurence Albiges, Axel Bex, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2024
Biological characterization of renal masses using immuno-PETFabrizia Gelardi, Alessandro Larcher, Lidija Antunovic, et al.
World Journal of Urology|June 9, 2014
Random biopsy: when, how many and where to take the cores?Vincenzo Scattoni, Carmen Maccagnano, Umberto Capitanio, et al.
European Urology|November 17, 2023
Reply to Jared P. Schober, Robert Wang, and Alexander Kutikov's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of <sup>99m</sup>Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol. 2023;85:63-71Giuseppe Basile, Giuseppe Fallara, Arturo Chiti, et al.
Pageof 52